BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/12/2024 3:55:59 PM | Browse: 115 | Download: 215
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 95854
Country Japan
Received
2024-04-20 16:53
Peer-Review Started
2024-04-20 16:53
First Decision by Editorial Office Director
2024-05-12 06:16
Return for Revision
2024-05-14 15:18
Revised
2024-05-21 06:09
Publication Fee Transferred
Second Decision by Editor
2024-06-03 02:40
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2024-06-03 06:31
Articles in Press
2024-06-03 06:31
Edit the Manuscript by Language Editor
2024-06-09 01:56
Typeset the Manuscript
2024-06-17 00:37
Publish the Manuscript Online
2024-07-12 15:55
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Case Report
Article Title BRAF K601E-mutated metastatic colorectal cancer in response to combination therapy with encorafenib, binimetinib, and cetuximab: A case report
Manuscript Source Unsolicited Manuscript
All Author List Makiko Sasaki, Takaya Shimura, Hirotada Nishie, Keita Kuroyanagi, Takuya Kanno, Shigeki Fukusada, Naomi Sugimura, Yusuke Mizuno, Takayuki Nukui, Konomu Uno, Yuki Kojima, Ruriko Nishigaki, Mamoru Tanaka, Keiji Ozeki, Eiji Kubota and Hiromi Kataoka
ORCID
Author(s) ORCID Number
Makiko Sasaki http://orcid.org/0000-0002-4196-7766
Takaya Shimura http://orcid.org/0000-0002-6048-0021
Hirotada Nishie http://orcid.org/0000-0003-2055-6519
Shigeki Fukusada http://orcid.org/0000-0001-6540-8742
Naomi Sugimura http://orcid.org/0000-0001-8658-1755
Takayuki Nukui http://orcid.org/0009-0007-5143-6567
Konomu Uno http://orcid.org/0009-0006-2164-5205
Yuki Kojima http://orcid.org/0000-0002-2008-9941
Ruriko Nishigaki http://orcid.org/0000-0002-1588-7084
Mamoru Tanaka http://orcid.org/0000-0001-8416-5774
Keiji Ozeki http://orcid.org/0000-0001-8034-9883
Eiji Kubota http://orcid.org/0000-0002-6694-8772
Hiromi Kataoka http://orcid.org/0000-0001-9491-0723
Funding Agency and Grant Number
Corresponding Author Takaya Shimura, MD, PhD, Associate Professor, Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Science, 1 Kawasumi, Mizuho, Nagoya 467-8601, Japan. tshimura@med.nagoya-cu.ac.jp
Key Words v-raf murine sarcoma viral oncogene homolog B K601E-mutation; Metastatic colorectal cancer; Encorafenib; Binimetinib; Cetuximab; Case report
Core Tip With the development and standardization of next-generation sequencing, it is anticipated that there will be an increased to discover previously unidentified genetic mutations. BRAF non-V600 mutations including K601E-mutation are rare mutation and the clinical behavior has not been understood. In this case, a comprehensive genomic profiling panel revealed a BRAF K601E mutation, which was not covered in the initial companion diagnostics. A combination of encorafenib, binimetinib, and cetuximab had great effect. It is important to consider the possibility of discovering rare mutations, which could expand treatment options.
Publish Date 2024-07-12 15:55
Citation

Sasaki M, Shimura T, Nishie H, Kuroyanagi K, Kanno T, Fukusada S, Sugimura N, Mizuno Y, Nukui T, Uno K, Kojima Y, Nishigaki R, Tanaka M, Ozeki K, Kubota E, Kataoka H. BRAF K601E-mutated metastatic colorectal cancer in response to combination therapy with encorafenib, binimetinib, and cetuximab: A case report. World J Gastrointest Oncol 2024; 16(7): 3357-3363

URL https://www.wjgnet.com/1948-5204/full/v16/i7/3357.htm
DOI https://dx.doi.org/10.4251/wjgo.v16.i7.3357
Full Article (PDF) WJGO-16-3357-with-cover.pdf
CARE Checklist–2016 95854-CARE-Checklist-2016.pdf
Manuscript File 95854-Review-Filipodia.docx
Answering Reviewers 95854-answering-reviewers.pdf
Audio Core Tip 95854-audio.mp3
Conflict-of-Interest Disclosure Form 95854-conflict-of-interest-statement.pdf
Copyright License Agreement 95854-copyright-assignment.pdf
Signed Consent for Treatment Form(s) or Document(s) 95854-informed-consent-statement.pdf
Non-Native Speakers of English Editing Certificate 95854-non-native-speakers.pdf
Peer-review Report 95854-peer-reviews.pdf
Scientific Misconduct Check 95854-scientific-misconduct-check.jpg
Scientific Editor Work List 95854-scientific-editor-work-list.pdf
CrossCheck Report 95854-crosscheck-report.pdf